← FDA Drug Approvals (Drugs@FDA)
CARBIDOPA AND LEVODOPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2024-06-04
Drug application
- FDA Application #
ANDA217482- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CARBIDOPA AND LEVODOPA
- Generic name
- CARBIDOPA AND LEVODOPA
- Active ingredients
- CARBIDOPA; LEVODOPA
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Advagen Pharma Ltd
- First approval
- 2024-06-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown